Our Parkinson's Place: IXICO PLC to support clinical trials for Parkinson's drug

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Monday, April 4, 2016

IXICO PLC to support clinical trials for Parkinson's drug

April 4, 2016

The study will see Ixico support the use of novel brain scanning techniques in phase I/II trials

The contract highlighted its growing reputation as leading provider of digital technology in brain health

Brain health company IXICO Plc (LON:IXI) has been awarded a contract by Oxford Biomedica to support

clinical trials of a new treatment for Parkinson’s disease.

The study, expected to start by the middle of this year, will see Ixico support the use of novel brain scanning techniques in phase I/II trials to test the experimental Parkinson’s drug, OXB-102.

The group will be involved in the trials for up to five years including follow up trials in the long term, to oversee the use of novel radiopharmaceutical ligands at specialist centres across Europe.

The contract highlighted the company’s growing reputation as a leading provider of digital technology in brain health, said chief executive Professor Derek Hill.

IXICO also announced that it had joined forces with seven global pharmaceutical companies

(including AstraZeneca, Biogen and Pfizer) to form the Critical Path for Parkinson’s consortium, formed by Parkinson’s UK.

The aim of the consortium is to standardise clinical trials, share

data and bring together researchers to develop safe and effective therapies for the disease.

“It is a privilege to be joining these major global pharmaceutical companies and Parkinson's UK in the Critical Path Institute's CPP consortium and to work together to accelerate progress in developing new therapies,” added Hill.

Shares stood at 39p.

http://www.proactiveinvestors.co.uk/companies/news/124388/ixico-plc-to-support-clinical-trials-for-parkinson-s-drug-124388.html